LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Publisher: Altai State University
Journal: Khimiia rastitel'nogo syr'ia (Chemistry of plant raw material)
Languages: Russian
Types: Article
Subjects: Schisandra chinensis, seeds oil extract, composition, content, standardization, лимонник китайский, масляный экстракт семян, лигнаны, состав, содержание, стандартизация
Fruits and seeds of Schisandra chinensis Turcz. (Baill.), fam. Schisandraceae are well known as adaptogens. Biological activity of Shisandra fruits and seeds is caused by special group of chemical compounds – lignans (shisandrins). The aim of the present work was to estimate possibility of extraction of lignans from S. chinensis seeds by fatty oils and further medicinal application of obtained extract.Extract from S. chinensis seeds with various fatty oils – corn oil, olive oil and helianthus oil, were obtained by original technology with rotor-pulsation apparatus. Qualitative and quantitative analysis was done by RP-HPLC method with standards of five shisandrins. Shisandrol A (about 0.1%), shisandrol B (about 0.083%), shisantherin А (about 0,022%), shisandrin А (about 0,018%), shisandrin B (about 0,09%) were identified in extracts. Total content of identified shisandrins was about 0.3%. There were not any significant differences on shisandrins composition for extracts received with use of various fatty oils. Relations between individual lignans were about 1:1:0,2:0,2:1 and is optimal for adaptogenic properties of Shisandra drugs.In biological experiments it was shown that oil extract of S. chinensis seeds is non toxic, safe for application, its pharmacological efficiency was revealed. Methods of standardization of extract as pharmaceutical substance were proposed and validated.It was estimated that density, refraction index and fatty acids composition (according to TLC after EP 6.0 test)) for initial oil and oil extract are identical or differ slightly, and the acid value considerably increases due to extractive substances from S. chinensis seeds. Application of single extraction procedure by methanol is proved for extract sample treatment for shisandrins quantification.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Panossian A., Wikman G. J. Ethnopharmacol, 2008, vol. 118, pp. 183-212.
    • 2. Gosudarstvennaja Farmakopeja SSSR, izd. 11-oe pererab. i dop. [State Pharmacopoeia of the USSR, vol. 11th Revised. and add.]. Issue 1, Moscow, 1987, 335 p.; issue 2, Moscow, 1989, 398 p. (in Russ.)
    • 3. Gosudarstvennaja Farmakopeja Rossijskoj Federacii, izd. 12-oe, Chast' 1. [State Pharmacopoeia of the Russian Federation, ed. 12th, Part 1.]. Moscow, 2008, 704 p. (in Russ.)
    • 4. European pharmacopoeia 6.0. art 2.3.2. Identification of fatty oils by thin-layer chromatography. Council of Europe, Strasbourg, 2007, 106 p.
    • 5. Ponomarev V.D. Jekstragirovanie lekarstvennogo syr'ja. [Extraction of medicinal raw materials]. Moscow, 1976, 117 p. (in Russ.)
    • 6. Kosman V.M., Pozharickaja O.N., Shikov A.N., Makarov V.G. Himiko-farmacevticheskij zhurnal, 2002, vol. 36, no. 2, pp. 43-45. (in Russ.)
    • 7. Shikov A.N., Makarov V.G., Ryzhenkov V.E. Rastitel'nye masla i masljanye jekstrakty: tehnologija, standar-tizacija, svojstva. [Vegetable oils and oil extracts: technology, standards-managing, properties]. Moscow, 2004, 264 p. (in Russ.)
    • 8. Pozharitskaya O.N., Ivanova S.A., Shikov A.N., Makarov V.G. J. Sep. Sci., 2007, vol. 30, pp. 1250-1254.
    • 9. Ivanova S.A., Pozharitskaya O.N., Demchenko D.V., Makarov V.G. Abstracts book of 16-th Int. Congress “Phytopharm 2012”, Saint-Petersburg, Russia, 9-11.07.2012, Moscow, 2012. Pp. 56-60.
    • 10. Makarenko I.E., Avdeeva O.I., Makarova M.N., Pozharitskaya O.N., Kryshen K.L. Abstracts book of 16-th Int. Congress “Phytopharm 2012”, Saint-Petersburg, Russia, 9-11.07.2012, Moscow, 2012. P. 63.
    • 11. Avdeeva O.I., Makarenko I.E., Makarov V.G., Simanovskaya M.S. Abstracts book of 16-th Int. Congress “Phytopharm 2012”, Saint-Petersburg, Russia, 9-11.07.2012, Moscow, 2012. P. 34.
    • 12. Gosselin R.E., Hodge H. C., Smith R.P., Gleason M.N. Clinical Toxicology of Commercial Products. Acute Poisoning. Ed. IV, Baltimore, 1975, 427 p.
    • 13. Karlina M.V., Kosman V.M., Pozharickaja O.N., Shikov A.N., Makarov V.G. Razrabotka i registracija lekarstvennyh sredstv, 2014, no. 1, pp. 236-133. (in Russ.)
    • 14. Pimenov A.I., Zenkevich I.G., Makarov V.G., Shikov A.N. Materialy VI Mezhdunarodnogo S#ezda «Aktual'nye problemy sozdanija novyh lekarstvennyh preparatov prirodnogo proishozhdenija». [Proceedings of the VI International Congress "Actual problems of creating new drugs of natural origin"]. St. Petersburg, 2002, pp. 278-282. (in Russ.)
    • 15. Rukovodstvo po validacii metodik analiza lekarstvennyh sredstv. [Manual validation of methods of analysis of drugs]. Moscow, 2007, 49 p. (in Russ.) Received March 20, 2014
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article